
Please try another search
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China. The company’s products include recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon Alfacon-2 Injection; and compound glycyrrhizin tablets, capsules, and injections, as well as pirfenidone tablets. The company was founded in 2008 and is based in Beijing, China.
Name | Age | Since | Title |
---|---|---|---|
Desheng Zhou | 54 | 2008 | President & Chairman of the Board |
Jifeng Shi | 51 | 2017 | VP, Chief Research Officer, Core Technical Personnel & Director |
Chen Du | 65 | 2020 | Independent Director |
Jianwei Zhu | 69 | 2021 | Independent Director |
Manli Sun | 55 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review